Skip to main content
Premium Trial:

Request an Annual Quote

Charles Sang

Adaptive Biotechnologies has appointed Charles Sang as senior vice president of diagnostics. He will be taking over from Tom Willis, who will be transitioning to an advisory role and will remain an active member on the company's board. Most recently, Sang served as the vice president of global diagnostics for nanostring technologies and led their North American and global commercial efforts for a new company's breast cancer prognostic gene signature assay.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.